Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 23, 2021 1:40pm
70 Views
Post# 34157997

RE:RE:RE:RE:.52

RE:RE:RE:RE:.52
boazklinghorn wrote: Proph has an excuse for everyday of the week, But seriously how much bigger than 400,000,000 is the YBG play. Entertain us with your wild predictions of our eventual riches.


Here is an estimate for IPF alone,

https://www.ihealthcareanalyst.com/global-idiopathic-pulmonary-fibrosis-treatment-market/

With commonality noted in fibrosis in different organs, an anti-firbrotic drug developed for the pulmonary system could have potential widespread applications. I'll leave it up to the experts, but am encouraged when Dr. Ask states, fibroisis is fibrosis is fibrosis.

Pre-clinical study results should be available by mid-February to mid-May, should they be successuful I would expect this study to garner a lot interest. 
<< Previous
Bullboard Posts
Next >>